ORANGE, Calif., Dec. 15, 2023 (GLOBE NEWSWIRE) -- via IBN -- Astiva Health Inc., a fast-growing Medicare Advantage Prescription Drug (MAPD) health plan dedicated to reshaping personalized and comprehensive healthcare, announced today that it has started the process of registering its common shares on the Nasdaq Global Select. The specifics of the number of shares to be offered and the price range are yet to be determined. The offer is contingent upon market conditions, and there is no assurance regarding the completion, size, or terms of the offering.
Astiva Health plans to file privately via DRS within the month of December, listing their Common Shares. Spartan Capital has been engaged as the banker/underwriter for this significant milestone in Astiva Health's journey. The company is targeting a Q1 IPO, pending approval by regulators. This announcement marks a crucial step for Astiva Health as it moves toward making a lasting impact in the healthcare industry.
Prospective investors are advised that the proposed offering will be conducted solely through a prospectus. Preliminary prospectus copies can be obtained, once available, by contacting Invest@AstivaHealth.com.
While a registration statement for these securities will be filed with the U.S. Securities ...